Chandru Ravindrakumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chandru Ravindrakumar has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Cunnigaiper Dhanasekaran Narayanan
Department of General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND
1 shared publication - Latha S.
Department of Pharmacognosy, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of HigherEducation and Research, Chennai, India
1 shared publication - Ludia John
General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India
1 shared publication Manuneethimaran Thiyagarajan
General Surgery Department, Sri Ramachandra Medical University, Chennai, India
1 shared publication- Rushab Ranawat
General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India
1 shared publication - Sailendra Mahanta
Structural Biology and Nanomedicine Laboratory, Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela 769008, Odisha, India
1 shared publication
Latest Publications
- 14 July 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 23, 1-21
Phytochemical-based Neuroprotection and In-silico Docking-driven Identification of Active Natural Compounds to Combat Neuropathy
Introduction: Neuropathic pain, a devastating neurological disorder attributed to impairment or malfunctioning of the somatosensory system, affecting 10% of the world population. Current therapy emphasizes symptomatic management, featuring high-order side effects. Phytocompounds as neuroprotective agents are of growing interest, and can be screened using structure-based docking, and can act upon a variety of pathways with fewer adverse effects. Methods: A comprehensive literature survey was conducted covering studies published between 2000 and 2022 using scientific databases including PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar. The neuroprotective potential of medicinal plants and their bioactive phytochemicals was screened using in silico experiments targeting neuropathy-related molecular targets, followed by the evaluation of in vitro and in vivo activities. Results: The studies showed that phytochemicals have multitarget neuroprotective activities, including antioxidant activity, modulation of neurotransmitter signaling, inhibition of inflammatory mediators, and modulation of neuropathic signaling ion channels. Several phytochemicals demonstrated notable binding affinities in docking studies, including icariin with NMDA receptors (−12.646 kcal/mol), aegeline with MAO-A (−10.06 kcal/mol) and MAO-B (−10.09 kcal/mol), and zerumbone with cannabinoid receptors CB1 (−7.80 kcal/mol) and CB2 (−9.40 kcal/mol). Other compounds, such as chlorogenic acid, myricetin, rutin, and piperine, also exhibited significant interactions with key neuropathic targets involved in neuroinflammation and pain signaling pathways. Discussion: Docking studies identified that icariin, aegeline, and zerumbone are predicted lead molecules because they can interact with targets of interest, including NMDA, MAO, and CB receptors. Conclusion: Phytochemical neuroprotective drugs offer a promising approach to managing neuropathy. Integration of molecular docking approaches with experimental pharmacological studies provides a powerful strategy for identifying bioactive natural compounds with therapeutic potential. These findings support advancing phytochemicals as lead candidates for the development of safer, more effective treatments for neuropathy and neuropathic pain
- 14 July 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 23, 1-21
Phytochemical-based Neuroprotection and In-silico Docking-driven Identification of Active Natural Compounds to Combat Neuropathy
Introduction: Neuropathic pain, a devastating neurological disorder attributed to impairment or malfunctioning of the somatosensory system, affecting 10% of the world population. Current therapy emphasizes symptomatic management, featuring high-order side effects. Phytocompounds as neuroprotective agents are of growing interest, and can be screened using structure-based docking, and can act upon a variety of pathways with fewer adverse effects. Methods: A comprehensive literature survey was conducted covering studies published between 2000 and 2022 using scientific databases including PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar. The neuroprotective potential of medicinal plants and their bioactive phytochemicals was screened using in silico experiments targeting neuropathy-related molecular targets, followed by the evaluation of in vitro and in vivo activities. Results: The studies showed that phytochemicals have multitarget neuroprotective activities, including antioxidant activity, modulation of neurotransmitter signaling, inhibition of inflammatory mediators, and modulation of neuropathic signaling ion channels. Several phytochemicals demonstrated notable binding affinities in docking studies, including icariin with NMDA receptors (−12.646 kcal/mol), aegeline with MAO-A (−10.06 kcal/mol) and MAO-B (−10.09 kcal/mol), and zerumbone with cannabinoid receptors CB1 (−7.80 kcal/mol) and CB2 (−9.40 kcal/mol). Other compounds, such as chlorogenic acid, myricetin, rutin, and piperine, also exhibited significant interactions with key neuropathic targets involved in neuroinflammation and pain signaling pathways. Discussion: Docking studies identified that icariin, aegeline, and zerumbone are predicted lead molecules because they can interact with targets of interest, including NMDA, MAO, and CB receptors. Conclusion: Phytochemical neuroprotective drugs offer a promising approach to managing neuropathy. Integration of molecular docking approaches with experimental pharmacological studies provides a powerful strategy for identifying bioactive natural compounds with therapeutic potential. These findings support advancing phytochemicals as lead candidates for the development of safer, more effective treatments for neuropathy and neuropathic pain
- 2 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e262238
Combined laparoscopic and gluteal approach for resection of a sciatic notch dumbbell lipoma
The greater sciatic, lesser sciatic and obturator foramina are openings in the pelvis through which pelvic lesions can herniate, leading to the formation of rare dumbbell tumours. We present the case of a man in his late 60s, who presented with obstructed defecation. A per rectal examination revealed a palpable right sided rectal mass. MRI pelvis identified a dumbbell lipoma traversing the right sciatic foramen, with a pelvic component causing displacement of the rectum and a gluteal component impinging on the sciatic nerve. The lipoma was successfully removed by a multidisciplinary team using a dual approach: the pelvic component was excised laparoscopically, and the gluteal component was removed by an open approach. Comprehensive knowledge of pelvic anatomy is required to safely and accurately excise lesions in this region. Laparoscopic approach offers clear advantages over the open approach, while yielding similar results.
- 2 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e262238
Combined laparoscopic and gluteal approach for resection of a sciatic notch dumbbell lipoma
The greater sciatic, lesser sciatic and obturator foramina are openings in the pelvis through which pelvic lesions can herniate, leading to the formation of rare dumbbell tumours. We present the case of a man in his late 60s, who presented with obstructed defecation. A per rectal examination revealed a palpable right sided rectal mass. MRI pelvis identified a dumbbell lipoma traversing the right sciatic foramen, with a pelvic component causing displacement of the rectum and a gluteal component impinging on the sciatic nerve. The lipoma was successfully removed by a multidisciplinary team using a dual approach: the pelvic component was excised laparoscopically, and the gluteal component was removed by an open approach. Comprehensive knowledge of pelvic anatomy is required to safely and accurately excise lesions in this region. Laparoscopic approach offers clear advantages over the open approach, while yielding similar results.
- Open Access
- 20 May 2018
- Published by Wiley in Minimally Invasive Surgery
- Vol. 2018, 1
Corrigendum to “A Comparative Study in Learning Curves of Two Different Intracorporeal Knot Tying Techniques”
[This corrects the article DOI: 10.1155/2016/3059434.].
- 20 May 2018
- Published by Wiley in Minimally Invasive Surgery
- Vol. 2018, 1
Open AccessCorrigendum to “A Comparative Study in Learning Curves of Two Different Intracorporeal Knot Tying Techniques”
[This corrects the article DOI: 10.1155/2016/3059434.].